Go Symbol Lookup
Loading...

Nasdaq Cancels Some Kraft Trades After Unusual Spike

 Text Size  
Published: Wednesday, 3 Oct 2012 | 11:07 AM ET
By: CNBC.com

Nasdaq said it is canceling some trades of Kraft Foods Groupstock after it spiked briefly on the Nasdaqstock exchange shortly after the market open.

The unusual trades prompted Nasdaq MarketWatch to begin an investigation into "potentially erroneous transactions" involving the company's shares.

The company's shares opened at $45.55 a share before surging to hit a high of $58.54. They are now trading about 1 percent higher than their opening price. Nasdaq said it would be canceling some trades above $47.82. (Click here to get the latest quotes for Kraft.)

Nasdaq Cancels Some Kraft Trades Above $47.82
CNBC's Bertha Coombs reports Kraft shares spiked in early trading and the Nasdaq is investigating potentially erroneous trades.

"Participants should review their trading activity for potentially erroneous trades and request adjudication through the Clearly Erroneous process within the applicable timeframe for filing pursuant to the rule," Nasdaq said in a release.

The unusual trading activity comes two days after Mondelez International, formerly Kraft Foods, spun off its North American grocery business into Kraft Foods Group.

 Print
Nasdaq said it is canceling some trades of Kraft Foods Group stock after it spiked briefly on the Nasdaq stock exchange shortly after the market open.
  Price   Change %Change
MDLZ ---
NDAQ ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

U.S. Video

  • Economic reports this week showed a strengthening economy. So why have stocks been so weak? Gina Sanchez, Chantico Global, and Peter Kenny, Knight Capital, share their opinions.

  • Shares of Pandora are up after the company reported earnings, reports CNBC's Seema Mody. And there are reports a deal between Valeant Pharmaceuticals and Bausch & Lomb could be completed as early as next week.

  • CNBC annual Top States for Business is coming up. A look at what is measured in comparing states, with CNBC's Scott Cohn.